Trial Outcomes & Findings for Treating People With Post-Traumatic Stress Disorder With Cognitive Behavioral Therapy for Insomnia (NCT NCT00881647)

NCT ID: NCT00881647

Last Updated: 2014-03-17

Results Overview

In a self-report sleep diary, participants were asked to report the length of time it takes from lying down for the night until sleep onset. This outcome consists of the posttreatment (CBT-I) or post-waitlist diary entry; In other words, each of the values below was measured at 8 weeks.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

45 participants

Primary outcome timeframe

After 8 weeks of study participation

Results posted on

2014-03-17

Participant Flow

Participant milestones

Participant milestones
Measure
CBT-I
8-week course of Cognitive Behavioral Treatment for Insomnia (CBT-I): CBT-I includes strategies and instructions targeted toward improving the quality of sleep and resolving problems falling and staying asleep
Waitlist
Participants placed on a waitlist for 8 weeks.
Overall Study
STARTED
29
16
Overall Study
COMPLETED
27
15
Overall Study
NOT COMPLETED
2
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Treating People With Post-Traumatic Stress Disorder With Cognitive Behavioral Therapy for Insomnia

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
CBT-I
n=29 Participants
8-week course of Cognitive Behavioral Treatment for Insomnia (CBT-I): CBT-I includes strategies and instructions targeted toward improving the quality of sleep and resolving problems falling and staying asleep
Waitlist
n=16 Participants
Participants placed on a waitlist for 8 weeks.
Total
n=45 Participants
Total of all reporting groups
Age, Continuous
37.1 years
STANDARD_DEVIATION 10.4 • n=5 Participants
37.3 years
STANDARD_DEVIATION 11.0 • n=7 Participants
37.2 years
STANDARD_DEVIATION 10.5 • n=5 Participants
Sex: Female, Male
Female
22 Participants
n=5 Participants
9 Participants
n=7 Participants
31 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
7 Participants
n=7 Participants
14 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
3 Participants
n=5 Participants
2 Participants
n=7 Participants
5 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
5 Participants
n=5 Participants
1 Participants
n=7 Participants
6 Participants
n=5 Participants
Race (NIH/OMB)
White
20 Participants
n=5 Participants
12 Participants
n=7 Participants
32 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Region of Enrollment
United States
29 participants
n=5 Participants
16 participants
n=7 Participants
45 participants
n=5 Participants
Marital Status
Single
20 participants
n=5 Participants
10 participants
n=7 Participants
30 participants
n=5 Participants
Marital Status
Married/Partnered
6 participants
n=5 Participants
2 participants
n=7 Participants
8 participants
n=5 Participants
Marital Status
Divorced
3 participants
n=5 Participants
3 participants
n=7 Participants
6 participants
n=5 Participants
Marital Status
Separated
0 participants
n=5 Participants
1 participants
n=7 Participants
1 participants
n=5 Participants
Veteran Status
Veteran
3 participants
n=5 Participants
6 participants
n=7 Participants
9 participants
n=5 Participants
Veteran Status
Not veteran
26 participants
n=5 Participants
10 participants
n=7 Participants
36 participants
n=5 Participants
PTSD Duration
20.4 years
STANDARD_DEVIATION 13.6 • n=5 Participants
15.0 years
STANDARD_DEVIATION 13.8 • n=7 Participants
18.5 years
STANDARD_DEVIATION 2.1 • n=5 Participants
Current Depression
Depressed
5 participants
n=5 Participants
4 participants
n=7 Participants
9 participants
n=5 Participants
Current Depression
Not depressed
24 participants
n=5 Participants
12 participants
n=7 Participants
36 participants
n=5 Participants
Using psychotropic medication
Using psychotropic medication
11 participants
n=5 Participants
7 participants
n=7 Participants
18 participants
n=5 Participants
Using psychotropic medication
Not using psychotropic medication
18 participants
n=5 Participants
9 participants
n=7 Participants
27 participants
n=5 Participants

PRIMARY outcome

Timeframe: After 8 weeks of study participation

In a self-report sleep diary, participants were asked to report the length of time it takes from lying down for the night until sleep onset. This outcome consists of the posttreatment (CBT-I) or post-waitlist diary entry; In other words, each of the values below was measured at 8 weeks.

Outcome measures

Outcome measures
Measure
CBT-I
n=27 Participants
8-week course of Cognitive Behavioral Treatment for Insomnia (CBT-I): CBT-I includes strategies and instructions targeted toward improving the quality of sleep and resolving problems falling and staying asleep
Waitlist
n=15 Participants
Participants placed on a waitlist for 8 weeks.
Sleep Latency (SL)
14.27 minutes
Standard Deviation 2.27
44.31 minutes
Standard Deviation 11.72

PRIMARY outcome

Timeframe: After 8 weeks of study participation

Population: per protocol

WASO was the sum of wake time during sleep as recorded in a self-report sleep diary, and as measured in epochs (30 seconds of polysomnography \[PSG\]) recording) after the onset of persistent sleep and prior to final awakening and wake time after sleep (the number of epochs after the final awakening until the end of PSG recording \[i.e. awake epoch immediately prior to the end of the recording\]). This outcome consists of posttreatment (CBT-I) or post-waitlist diary entries and polysomnography data; In other words, each of the values below was measured at 8 weeks.

Outcome measures

Outcome measures
Measure
CBT-I
n=27 Participants
8-week course of Cognitive Behavioral Treatment for Insomnia (CBT-I): CBT-I includes strategies and instructions targeted toward improving the quality of sleep and resolving problems falling and staying asleep
Waitlist
n=15 Participants
Participants placed on a waitlist for 8 weeks.
Minutes of Wake After Sleep Onset (WASO)
WASO by self report
13.82 Minutes
Standard Deviation 2.03
47.25 Minutes
Standard Deviation 11.45
Minutes of Wake After Sleep Onset (WASO)
WASO by PSG
39.25 Minutes
Standard Deviation 7.73
57.63 Minutes
Standard Deviation 18.28

PRIMARY outcome

Timeframe: After 8 weeks of study participation

SE, as determined by polysomnography (PSG) and by self-reported sleep diary, was the total sleep time (TST) divided by the time in bed, multiplied by 100. This outcome consists of posttreatment (CBT-I) or post-waitlist diary entries and polysomnography data; In other words, each of the values below was measured at 8 weeks.

Outcome measures

Outcome measures
Measure
CBT-I
n=27 Participants
8-week course of Cognitive Behavioral Treatment for Insomnia (CBT-I): CBT-I includes strategies and instructions targeted toward improving the quality of sleep and resolving problems falling and staying asleep
Waitlist
n=15 Participants
Participants placed on a waitlist for 8 weeks.
Sleep Efficiency (SE)
SE by self-report
93.72 percentage of time
Standard Deviation 0.93
81.77 percentage of time
Standard Deviation 2.47
Sleep Efficiency (SE)
SE by PSG
91.35 percentage of time
Standard Deviation 1.91
88.14 percentage of time
Standard Deviation 3.59

Adverse Events

CBT-I

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Waitlist

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Thomas C. Neylan, MD

University of California, San Francisco

Phone: 415-750-6961

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place